Power Mobility Device (PMD) Prior Authorization Demonstration Project
- Centers for Medicare & Medicaid Services (CMS) Prior Authorization Resources
- CGS Power Mobility Documentation Resources
- CMS Signature Requirements
- Dear Supplier Letter: Prior Authorization Demonstration Project
- Jurisdiction C Prior Authorization Demonstration Project Status Report: Spring 2013
- MLN Matters Article SE1112: Power Mobility Device Face-to-Face Examination Checklist
- PMD Demonstration Operational Guide - New!
- PMD Denial Help Aid
- PMD Prior Authorization Demonstration Claim Reminders
- PMD Prior Authorization and Upgrades - New!
- Prior Authorization Request Coversheet
On September 1, 2012, the Medicare Fee-For-Service Program began conducting a three-year prior authorization demonstration project for certain Power Mobility Devices (PMD). In Jurisdiction C, this demonstration project applies to beneficiaries permanently residing in North Carolina, Florida or Texas.
Effective October 1, 2014, the demonstration was expanded to included beneficiaries permanently residing in the states of Georgia, Louisiana, and Tennessee.The prior authorization process under this demonstration is available for PMD orders written on or after September 1, 2012, for NC, FL, and TX, and October 1, 2014, for GA, LA, and TN, for the following Healthcare Common Procedure Coding System (HCPCS) codes:
- Group 1 Power Operated Vehicles (K0800 – K0802 and K0812),
- All Group 1 and Group 2 standard power wheelchairs (K0813 – K0829),
- All Group 2 complex rehabilitative power wheelchairs (K0835 – K0843),
- All Group 3 complex rehabilitative power wheelchairs without power options (K0848 – K0855),
- Pediatric power wheelchairs (K0890 – K0891); and
- Miscellaneous power wheelchairs (K0898).
A Prior Authorization Request (PAR) may be submitted by either the treating physician/practitioner or the supplier. Before sending the request, the submitter should complete a Prior Authorization Request Coversheet (see link above). The PAR must include the following documentation:
- Completed PAR coversheet,
- 7-element written order,
- Treating physician/practitioner face-to-face assessment,
- Detailed product description,
- Specialty evaluation (if required by policy); and
- Other relevant medical documentation.
The request may be mailed or faxed as follows:
|Fax the PAR to:||615-664-5960|
|Mail the PAR to:||CGS – DME Medical Review – Prior Authorization
PO Box 24890
Nashville, TN 37202-4890
After receipt of all relevant documentation, CGS will review and communicate a decision within 10 business days. The decision letter regarding prior authorization (affirmative or non-affirmative) will be sent to the treating physician/practitioner, the supplier and the Medicare beneficiary. In the event of a non-affirmative decision, the letter will explain why the PAR was not affirmed. The letter will additionally provide a prior authorization tracking number that should be submitted with the PMD claim.
Please note that prior authorization is not mandatory. However without a prior authorization decision, if a claim for one of the HCPCS codes listed above is submitted for a beneficiary residing in any of the demonstration states listed above, the claim will be stopped for review. At that time, CGS will send the supplier an Additional Documentation Request (ADR) letter and the supplier must respond within 45 days by providing all requested documentation. Additionally, starting December 1, 2012, CMS will assess a 25 percent payment reduction on a supplier's payable claim when the first claim is not preceded by a PAR.
There is an exception to the 25 percent reduction in payment for competitive bidding contract suppliers submitting a payable claim for a beneficiary with a permanent residence in a competitive bidding area. The competitive bid supplier will receive the contractual single payment amount under their contract. These suppliers, however, must adhere to all other requirements of the demonstration.
For additional information concerning the PMD prior authorization demonstration project, please refer to the above web links.